Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registry-Reference-Cited by-同舟云学术

Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registry

Published:2024-02 Issue: Volume:139 Page:13-20
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Mostaghim Anahita^ORCID,Minkove Samuel^ORCID,Aguilar-Company Juan^ORCID,Ruiz-Camps Isabel,Eremiev-Eremiev Simeon,Dettorre Gino M.^ORCID,Fox Laura,Tondini Carlo,Brunet Joan^ORCID,Carmona-García MCarmen^ORCID,Lambertini Matteo^ORCID,Bower Mark,Newsom-Davis Thomas,Sharkey Rachel,Pria Alessia Dalla,Rossi Maura,Plaja Andrea,Salazar Ramon,Sureda Anna,Prat Aleix,Michalarea Vasiliki^ORCID,Van Hemelrijck Mieke,Sita-Lumsden Ailsa,Bertuzzi Alexia,Rimassa Lorenza,Rossi Sabrina,Rizzo Gianpiero^ORCID,Pedrazzoli Paolo,Lee Alvin JX^ORCID,Murphy Cian^ORCID,Belessiotis Katherine,Diamantis Nikolaos,Mukherjee Uma,Pommeret Fanny,Stoclin Annabelle^ORCID,Martinez-Vila Clara,Bruna Riccardo,Gaidano Gianluca^ORCID,D'Avanzo Francesca,Gennari Alessandra,Athale Janhavi,Eichacker Peter,Pinato David J.,Torabi-Parizi Parizad^ORCID,Cortellini Alessio^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference32 articles.

1. Immune checkpoint blockade: a common denominator approach to cancer therapy;Topalian;Cancer Cell,2015

2. Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors;Bersanelli;Immunotherapy,2020

3. At the crossroads: COVID-19 and immune-checkpoint blockade for cancer;Garassino;Cancer Immunol Res,2021

4. Do checkpoint inhibitors compromise the cancer patients' immunity and increase the vulnerability to COVID-19 infection?;Kattan;Immunotherapy,2020

5. Cancer and immune checkpoint inhibitor treatment in the era of SARS-CoV-2 infection;Gambichler;Cancers,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune checkpoint inhibitors and SARS-CoV2 infection;International Immunopharmacology;2024-08

2. Anti-PD-L1 therapy altered inflammation but not survival in a lethal murine hepatitis virus-1 pneumonia model;Frontiers in Immunology;2024-01-08